Ozempic Users Lose Hunger for Life Too
Source: thefp.com
TL;DR
- Ozempic users report losing desire for food and other life activities after starting the drug.
- Kim Francis lost 25 pounds, quit drinking, but feels "gray" and worthless for 48 hours weekly post-injection.[[1]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on?utm_source=x&utm_medium=paid-social&utm_campaign=content&utm_content=ozempicdepression&utm_adgroup=broad&utm_adid=&twclid=21469pqk3fur7fozscg3nji81y)[[2]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on)
- Weight loss comes with emotional trade-offs like apathy that make users question if life improved.
The story at a glance
Evan Gardner profiles Ozempic and GLP-1 drug users like Kim Francis, who started the shot in June 2023 for uncontrolled blood sugar, weight, arthritis, and type 2 diabetes. It curbed her food and alcohol cravings, eased joint pain, dropped her weight, and let her hit the gym daily. The piece is out now amid surging popularity—nearly 12% of Americans have tried these drugs—raising questions about unknown side effects like emotional flatness.[[3]](https://www.rand.org/news/press/2025/08/nearly-12-percent-of-americans-have-used-glp-1-weight.html)
Key points
- Kim Francis went from daily drinks to one a month, lost 25 pounds, slept through the night, and gained freedom for gym and other activities she skipped before.[[1]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on?utm_source=x&utm_medium=paid-social&utm_campaign=content&utm_content=ozempicdepression&utm_adgroup=broad&utm_adid=&twclid=21469pqk3fur7fozscg3nji81y)
- Post-injection, first 48 hours bring severe emotional lows: her "mind and day-to-day is kind of gray," she feels "worthless," and "doesn't want to be involved in life."[[1]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on?utm_source=x&utm_medium=paid-social&utm_campaign=content&utm_content=ozempicdepression&utm_adgroup=broad&utm_adid=&twclid=21469pqk3fur7fozscg3nji81y)
- Drugs kill desire to eat—and possibly to do anything; Gardner spoke to multiple GLP-1 users facing similar apathy trade-offs despite physical gains.[[2]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on)
- Popularity is huge: now "as American as apple pie," with a recent RAND survey showing 11.8% U.S. use, highest among women 50-64 at 20%.[[3]](https://www.rand.org/news/press/2025/08/nearly-12-percent-of-americans-have-used-glp-1-weight.html)
- We lack full knowledge of how these drugs work, contrasting a new study claiming mental health boosts from reduced cravings.[[2]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on)
Details and context
The article spotlights a downside to GLP-1 drugs like Ozempic (semaglutide): they mimic a gut hormone to suppress appetite, but user stories suggest broader blunting of motivation and joy, at least short-term after weekly shots. Francis calls it her "trade-off of weight loss"—physical wins like no more chronic pain, but two days weekly of feeling detached from life.
This fits reports from other users of anhedonia or "Ozempic apathy," where hunger for food, drink, or engagement fades. While a brand-new study says the drugs aid mental health via craving cuts, anecdotes point to risks like lethargy or depression in some, especially early on.[[2]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on)
Usage has exploded since 2023, driven by diabetes control and weight loss hype, but long-term effects on mood and drive remain unclear.
Key quotes
“My mind and my day-to-day is kind of gray.” —Kim Francis, Ozempic user[[1]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on?utm_source=x&utm_medium=paid-social&utm_campaign=content&utm_content=ozempicdepression&utm_adgroup=broad&utm_adid=&twclid=21469pqk3fur7fozscg3nji81y)
“I just feel worthless... You don’t want to be involved in life for two days of every week.” —Kim Francis[[1]](https://www.thefp.com/p/they-went-on-ozempic-and-gave-up-on?utm_source=x&utm_medium=paid-social&utm_campaign=content&utm_content=ozempicdepression&utm_adgroup=broad&utm_adid=&twclid=21469pqk3fur7fozscg3nji81y)
Why it matters
These stories highlight hidden costs of GLP-1 drugs amid their boom, questioning if curbed obesity trades for dulled human drive. Users like Francis weigh better health against feeling detached, while millions more may face similar choices without full warnings. Watch for more user reports, studies on mood effects, and doctor guidance as use grows.